The Arvix BioMatrix™ platform is a modular biologic system comprising Base™, Core™, and Prime™ components designed to ...
The new product offering will supply global life science researchers with performance and reliability in multi-fragment ...
NANJING, JIANGSU, CHINA, February 6, 2026 /EINPresswire.com/ -- The crisp mountain air calls for gear that respects the ...
AGNi is different from today’s AI and AGI approaches, geared to maximize the user’s benefit to advance health and ...
The social media service formerly known as Twitter is down on Feb. 16, with reports beginning around 8 a.m. EST.
The Department of Energy's Oak Ridge National Laboratory has launched a novel robotic platform to rapidly analyze plant root systems as they grow, yielding AI-ready data to accelerate the development ...
With biotech venture funding down 40% from peak levels and investor selectivity at historic highs, operational expertise has ...
Clinical Trials Arena on MSN
Oncology trial systems debut at SCOPE 2026 as AI adoption accelerates
Massive Bio and ConcertAI revealed the AI oncology trial systems at SCOPE 2026.
Bio-Rad remains undervalued, but persistent end-market headwinds and limited core growth drivers temper my conviction. BIO's valuation is heavily influenced by its substantial Sartorius stake, and the ...
Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generation Bio, which once ...
KALA BIO, Inc. (NASDAQ: KALA) shares jumped 22.16% to $1.13 in after-hours trading on Wednesday. Check out the current price of KALA stock here. Securities and Exchange Commission filings indicate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results